Skip to content

DIEPENBEEK MARKT FARMA

Active
Public limited companyfounded 1999active for 27 yearsMarktplein 20-21, 3590 Diepenbeek, BelgiumKBO/BCE: BE 0467.158.334
Summary

DIEPENBEEK MARKT FARMA has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €242,155 and a net result of €81,175. Equity is shrinking by about 3.6% per year across the filed financial years. Its solvency ranks better than 62% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
DIEPENBEEK MARKT FARMAActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.0mturnover 2025, estimated
Staff
1.9 FTE
Equity
€242,155
Profit
€81,175
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
KREPHI · 100%
  • KREPHIManaging director · permanent representative KREEMERS Koen Bert Françis
  • PHILIPS IngeDirector
2025 accounts 57 days early2 of 6 deeds summarised
Why 95raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.77, cash €122,683Equity €242,155 (47.9% of total assets)Founded in 1999Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 61% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 73+3
equity 47.9% of total assets
Liquidity 54+4
short-term debt 52.1% · cash 24.3%
Profitability 89-11
return on assets 16.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025highest value 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €23,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.77, compared with 1.7 in 2024, above the usual 1.5; short-term debt: 52.1% and cash: 24.3% of total assets), but 52.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 62% on solvency, 59% on liquidity, 84% on profitability and 38% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.77, cash €122,683
NBB · annual accounts
lowers risk · Equity €242,155 (47.9% of total assets)
NBB · annual accounts
lowers risk · Founded in 1999
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €242,155
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-06-2026, 57 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
57 days early
2024
43 days early
2023
36 days early
2022
42 days early
2021
47 days early
2020
58 days early
2019
57 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 49 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Highest result from 2018 to 2025net €148,515 ▲727%

Key points

  • Caution: Result fell in 2025from €148,515 to €81,175 ▼ 45.3% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €81,175 8 years View
  • Controlled by KREPHI 100% View

By topic

Financials

Financial year
2025
Total assets
€505,908
Profit
€81,175
Solvency
47.9%
Total assets▼ 6.4%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
KREPHI · 100%
  • KREPHIManaging director
  • PHILIPS IngeDirector
Go to Board & ownership

Timeline

Events
30
Since
2001
Next accounts
by 31-07-2027
  1. 25-06-2024Annual accounts filed
  2. 31-12-2023Weakest financial year
  3. 16-11-2023Appointments: KREPHI (director) and PHILIPS Inge (director)
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
27-10-1999
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
37
Purpose
“De uitbating van één of meerdere apotheken, groothandel, de aan- en verkoop, de bereiding…” (deed in Dutch)
Go to Articles of association

Key facts about DIEPENBEEK MARKT FARMA

What is the company number of DIEPENBEEK MARKT FARMA?
0467.158.334. In Belgium the VAT number is the company number with BE in front: BE 0467.158.334.
Where is DIEPENBEEK MARKT FARMA based?
The registered office is at Marktplein 20-21, 3590 Diepenbeek.Company details
What does DIEPENBEEK MARKT FARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of DIEPENBEEK MARKT FARMA?
Public limited company (NV).
When was DIEPENBEEK MARKT FARMA founded?
On 27-10-1999.
Is DIEPENBEEK MARKT FARMA still active?
Yes, DIEPENBEEK MARKT FARMA is an active enterprise in the KBO register.
How many employees does DIEPENBEEK MARKT FARMA have?
On average 1.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DIEPENBEEK MARKT FARMA?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DIEPENBEEK MARKT FARMA profitable?
In financial year 2025, DIEPENBEEK MARKT FARMA made a profit of €81,175.
Where can I find the annual accounts of DIEPENBEEK MARKT FARMA?
DIEPENBEEK MARKT FARMA filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DIEPENBEEK MARKT FARMA due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DIEPENBEEK MARKT FARMA

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure